Analysts forecast solid earnings growth for all divisions of COG Financial Services over FY26-27
It’s been a long road for medical device manufacturer ImpediMed, but analysts believe the company is now ready to increase scale
Imdex has continued to pay up for strategic acquisitions with the latest offerings serving up growth opportunities across products, software and geographic regions
While a stripped-down Premier Investments’ flagship brand Peter Alexander continues to perform well, Smiggle remains a problem child
Gentrack’s FY25 results calmed investor concerns with the future stock re-rating reliant on converting a robust pipeline to new contract wins, albeit delayed
Web Travel’s interim results provide analysts with increased confidence in management achieving FY27 goals
New research shows a strong growth outlook for renewable energy business LGI which provides exposure to the decarbonisation theme
Weak demand for lifestyle footwear has led to a shock downgrade from Accent Group. Across-the-board downgrades have followed
Used car enterprise Carma listed earlier this month, raising $100m via its IPO
Nufarm posted a better than feared FY25 result, surprised by deciding to retain its Seeds business, and has optimistic growth targets for FY26